The evolution of intravascular lithotripsy (IVL) continues to accelerate, changing how physicians treat calcified arterial lesions. All IVL systems rely on sonic pressure waves to fracture calcium deposits — but not all IVL energy is delivered in the same way.
What distinguishes next-generation platforms is their energy delivery (pulse frequency) capabilities and the physician’s ability to control this during procedures.
For readers new to IVL technology: Think of it as the difference between a single lightning strike versus a controlled electrical storm. A single strike might crack a rock, but it's unpredictable and limited to one spot. A controlled storm can deliver multiple precise strikes exactly where needed, covering more area with consistent power. In IVL, this can translate to faster treatment times, more uniform calcium fracturing, and better outcomes for patients.
The progression from legacy systems to next-generation IVL platforms represents more than incremental improvement — it's a shift from proving the concept to enabling precision treatment for peripheral artery disease (PAD) and coronary artery disease (CAD) — both of which kill millions of people globally.
How well next-generation IVL platforms overcome the challenges of earlier systems will determine how efficiently and precisely therapy can be delivered.
This article examines how pulse frequency and energy control have evolved across leading IVL platforms, the effect they have on therapy delivery, and the impact on procedures, safety, and physician workflow.
The evolution of intravascular lithotripsy (IVL) continues to accelerate, changing how physicians treat calcified arterial lesions. All IVL systems rely on sonic pressure waves to fracture calcium deposits — but not all IVL energy is delivered in the same way.
What distinguishes next-generation platforms is their energy delivery (pulse frequency) capabilities and the physician’s ability to control this during procedures.
For readers new to IVL technology: Think of it as the difference between a single lightning strike versus a controlled electrical storm. A single strike might crack a rock, but it's unpredictable and limited to one spot. A controlled storm can deliver multiple precise strikes exactly where needed, covering more area with consistent power. In IVL, this can translate to faster treatment times, more uniform calcium fracturing, and better outcomes for patients.
The progression from legacy systems to next-generation IVL platforms represents more than incremental improvement — it's a shift from proving the concept to enabling precision treatment for peripheral artery disease (PAD) and coronary artery disease (CAD) — both of which kill millions of people globally.
How well next-generation IVL platforms overcome the challenges of earlier systems will determine how efficiently and precisely therapy can be delivered.
This article examines how pulse frequency and energy control have evolved across leading IVL platforms, the effect they have on therapy delivery, and the impact on procedures, safety, and physician workflow.
The evolution of intravascular lithotripsy (IVL) continues to accelerate, changing how physicians treat calcified arterial lesions. All IVL systems rely on sonic pressure waves to fracture calcium deposits — but not all IVL energy is delivered in the same way.
What distinguishes next-generation platforms is their energy delivery (pulse frequency) capabilities and the physician’s ability to control this during procedures.
For readers new to IVL technology: Think of it as the difference between a single lightning strike versus a controlled electrical storm. A single strike might crack a rock, but it's unpredictable and limited to one spot. A controlled storm can deliver multiple precise strikes exactly where needed, covering more area with consistent power. In IVL, this can translate to faster treatment times, more uniform calcium fracturing, and better outcomes for patients.
The progression from legacy systems to next-generation IVL platforms represents more than incremental improvement — it's a shift from proving the concept to enabling precision treatment for peripheral artery disease (PAD) and coronary artery disease (CAD) — both of which kill millions of people globally.
How well next-generation IVL platforms overcome the challenges of earlier systems will determine how efficiently and precisely therapy can be delivered.
This article examines how pulse frequency and energy control have evolved across leading IVL platforms, the effect they have on therapy delivery, and the impact on procedures, safety, and physician workflow.
The evolution of intravascular lithotripsy (IVL) continues to accelerate, changing how physicians treat calcified arterial lesions. All IVL systems rely on sonic pressure waves to fracture calcium deposits — but not all IVL energy is delivered in the same way.
What distinguishes next-generation platforms is their energy delivery (pulse frequency) capabilities and the physician’s ability to control this during procedures.
For readers new to IVL technology: Think of it as the difference between a single lightning strike versus a controlled electrical storm. A single strike might crack a rock, but it's unpredictable and limited to one spot. A controlled storm can deliver multiple precise strikes exactly where needed, covering more area with consistent power. In IVL, this can translate to faster treatment times, more uniform calcium fracturing, and better outcomes for patients.
The progression from legacy systems to next-generation IVL platforms represents more than incremental improvement — it's a shift from proving the concept to enabling precision treatment for peripheral artery disease (PAD) and coronary artery disease (CAD) — both of which kill millions of people globally.
How well next-generation IVL platforms overcome the challenges of earlier systems will determine how efficiently and precisely therapy can be delivered.
This article examines how pulse frequency and energy control have evolved across leading IVL platforms, the effect they have on therapy delivery, and the impact on procedures, safety, and physician workflow.
In a Flash⚡
Energy Control & Frequency
What is pulse frequency in IVL?
Pulse frequency in intravascular lithotripsy (IVL) is the rate at which a system delivers sonic pressure waves, typically measured in Hertz (Hz), or pulses per second. A higher frequency results in more pulses per second — reducing procedure time and minimizing ischemic burden.¹
What is energy control and targeting in IVL?
In IVL, energy control and targeting refer to the system's ability to precisely direct sonic pressure waves to calcified plaque. This includes both cross-sectional coverage (around the vessel's circumference) and longitudinal coverage (along the vessel's length). Effective targeting ensures comprehensive energy delivery across the entire lesion, minimizing the need for repeated balloon repositioning and reducing the risk of under-treated segments. Precision is essential for procedural efficiency and optimal clinical outcomes, especially in long, diffuse, eccentric, or nodular lesions.
What sets FastWave’s control and frequency apart?
Existing IVL systems are limited to 1–2 Hz and often require repeated balloon repositioning to treat multiple segments. In contrast, FastWave’s Artero™ (E-IVL) delivers energy at 4 Hz with independent emitter activation, enabling more consistent longitudinal coverage. FastWave’s Sola™ (L-IVL) system delivers pulses at 5 Hz and features a physician-controlled translating emitter, allowing precise therapy delivery within a single inflation — without repositioning the balloon.
How Does Pulse Frequency Affect Treatment Speed and Safety?
Pulse frequency — measured in hertz (Hz) — determines how many sonic pressure waves an IVL system can deliver per second. This technical specification has direct clinical consequences: the faster the pulse rate, the more quickly a system can deliver its full therapeutic dose of energy pulses, which means shorter procedure times and reduced ischemia for the patient. When a balloon is inflated during IVL therapy, it temporarily blocks blood flow to the tissue — so minimizing this inflation time can be critical for patient safety and procedural success.
For example, legacy IVL coronary systems deliver energy at a rate of 1 Hz, meaning each pulse is separated by a full second. A typical 120-pulse catheter requires a balloon to be deflated and reinflated every 10 pulses, which means it will take at least 4 minutes for the physician to deliver IVL therapy. Not only does this prolong the procedure, but it could extend the ischemic window, which is especially problematic in coronary interventions or for patients with compromised cardiac output.
First-generation IVL systems: Deliver pulses at a frequency of 1–2 Hz, depending on the specific catheter platform. Coronary IVL catheters operate at 1 Hz while some peripheral versions fire at a faster 2 Hz rate. Therefore, even at its fastest, procedure times can be prolonged when using legacy IVL devices.
FastWave Artero™: Designed for 4 Hz pulse delivery. This means the full set of 400+ pulses can be delivered up to 4x faster than first-generation IVL systems — improving procedural efficiency, especially for long, diffuse disease in the periphery.
FastWave Sola™: Engineered to offer an even faster rate — 5 Hz — delivering over 300 pulses in rapid succession. Faster pulse delivery allows operators to complete therapy quicker with less concern about ischemia in patients with compromised cardiac output.
How Does Pulse Frequency Affect Treatment Speed and Safety?
Pulse frequency — measured in hertz (Hz) — determines how many sonic pressure waves an IVL system can deliver per second. This technical specification has direct clinical consequences: the faster the pulse rate, the more quickly a system can deliver its full therapeutic dose of energy pulses, which means shorter procedure times and reduced ischemia for the patient. When a balloon is inflated during IVL therapy, it temporarily blocks blood flow to the tissue — so minimizing this inflation time can be critical for patient safety and procedural success.
For example, legacy IVL coronary systems deliver energy at a rate of 1 Hz, meaning each pulse is separated by a full second. A typical 120-pulse catheter requires a balloon to be deflated and reinflated every 10 pulses, which means it will take at least 4 minutes for the physician to deliver IVL therapy. Not only does this prolong the procedure, but it could extend the ischemic window, which is especially problematic in coronary interventions or for patients with compromised cardiac output.
First-generation IVL systems: Deliver pulses at a frequency of 1–2 Hz, depending on the specific catheter platform. Coronary IVL catheters operate at 1 Hz while some peripheral versions fire at a faster 2 Hz rate. Therefore, even at its fastest, procedure times can be prolonged when using legacy IVL devices.
FastWave Artero™: Designed for 4 Hz pulse delivery. This means the full set of 400+ pulses can be delivered up to 4x faster than first-generation IVL systems — improving procedural efficiency, especially for long, diffuse disease in the periphery.
FastWave Sola™: Engineered to offer an even faster rate — 5 Hz — delivering over 300 pulses in rapid succession. Faster pulse delivery allows operators to complete therapy quicker with less concern about ischemia in patients with compromised cardiac output.
How Does Pulse Frequency Affect Treatment Speed and Safety?
Pulse frequency — measured in hertz (Hz) — determines how many sonic pressure waves an IVL system can deliver per second. This technical specification has direct clinical consequences: the faster the pulse rate, the more quickly a system can deliver its full therapeutic dose of energy pulses, which means shorter procedure times and reduced ischemia for the patient. When a balloon is inflated during IVL therapy, it temporarily blocks blood flow to the tissue — so minimizing this inflation time can be critical for patient safety and procedural success.
For example, legacy IVL coronary systems deliver energy at a rate of 1 Hz, meaning each pulse is separated by a full second. A typical 120-pulse catheter requires a balloon to be deflated and reinflated every 10 pulses, which means it will take at least 4 minutes for the physician to deliver IVL therapy. Not only does this prolong the procedure, but it could extend the ischemic window, which is especially problematic in coronary interventions or for patients with compromised cardiac output.
First-generation IVL systems: Deliver pulses at a frequency of 1–2 Hz, depending on the specific catheter platform. Coronary IVL catheters operate at 1 Hz while some peripheral versions fire at a faster 2 Hz rate. Therefore, even at its fastest, procedure times can be prolonged when using legacy IVL devices.
FastWave Artero™: Designed for 4 Hz pulse delivery. This means the full set of 400+ pulses can be delivered up to 4x faster than first-generation IVL systems — improving procedural efficiency, especially for long, diffuse disease in the periphery.
FastWave Sola™: Engineered to offer an even faster rate — 5 Hz — delivering over 300 pulses in rapid succession. Faster pulse delivery allows operators to complete therapy quicker with less concern about ischemia in patients with compromised cardiac output.
How Does Pulse Frequency Affect Treatment Speed and Safety?
Pulse frequency — measured in hertz (Hz) — determines how many sonic pressure waves an IVL system can deliver per second. This technical specification has direct clinical consequences: the faster the pulse rate, the more quickly a system can deliver its full therapeutic dose of energy pulses, which means shorter procedure times and reduced ischemia for the patient. When a balloon is inflated during IVL therapy, it temporarily blocks blood flow to the tissue — so minimizing this inflation time can be critical for patient safety and procedural success.
For example, legacy IVL coronary systems deliver energy at a rate of 1 Hz, meaning each pulse is separated by a full second. A typical 120-pulse catheter requires a balloon to be deflated and reinflated every 10 pulses, which means it will take at least 4 minutes for the physician to deliver IVL therapy. Not only does this prolong the procedure, but it could extend the ischemic window, which is especially problematic in coronary interventions or for patients with compromised cardiac output.
First-generation IVL systems: Deliver pulses at a frequency of 1–2 Hz, depending on the specific catheter platform. Coronary IVL catheters operate at 1 Hz while some peripheral versions fire at a faster 2 Hz rate. Therefore, even at its fastest, procedure times can be prolonged when using legacy IVL devices.
FastWave Artero™: Designed for 4 Hz pulse delivery. This means the full set of 400+ pulses can be delivered up to 4x faster than first-generation IVL systems — improving procedural efficiency, especially for long, diffuse disease in the periphery.
FastWave Sola™: Engineered to offer an even faster rate — 5 Hz — delivering over 300 pulses in rapid succession. Faster pulse delivery allows operators to complete therapy quicker with less concern about ischemia in patients with compromised cardiac output.
Therapy Delivery
240 seconds (1 Hz)
32 seconds (5 Hz)
Cycle Pause Periods
240 seconds
Few pulses at slower frequency
(1-2 Hz) result in longer procedures
0 seconds
More pulses at faster frequency
(4 Hz)
Treatment Length
12mm
Few pulses at slower frequency
(1-2 Hz) result in longer procedures
24mm
More pulses at faster frequency
(4 Hz)
Total Therapy Time
240 seconds*
32 seconds*
*FastWave's 24mm length balloon does not require repositioning compared to the 12mm length balloons
with first-generation IVL technology.
First-Generation IVL
Therapy Delivery
240 seconds (1 Hz)
Cycle Pause Periods
240 seconds
Treatment Length
12mm
Total Therapy Time
480 seconds*
First-Generation IVL
Therapy Delivery
240 seconds (1 Hz)
Cycle Pause Periods
240 seconds
Treatment Length
12mm
Total Therapy Time
480 seconds*
First-Generation IVL
Therapy Delivery
240 seconds (1 Hz)
Cycle Pause Periods
240 seconds
Treatment Length
12mm
Total Therapy Time
480 seconds*
First-Generation IVL
Therapy Delivery
240 seconds (1 Hz)
Cycle Pause Periods
240 seconds
Treatment Length
12mm
Total Therapy Time
480 seconds*
Why it matters: Higher pulse frequencies fundamentally change IVL's risk-benefit equation. Reducing repeated balloon inflations makes IVL potentially more viable for patients who couldn't previously tolerate the procedure — those with severely reduced cardiac function or multi-vessel disease.
Why it matters: Higher pulse frequencies fundamentally change IVL's risk-benefit equation. Reducing repeated balloon inflations makes IVL potentially more viable for patients who couldn't previously tolerate the procedure — those with severely reduced cardiac function or multi-vessel disease.
Why it matters: Higher pulse frequencies fundamentally change IVL's risk-benefit equation. Reducing repeated balloon inflations makes IVL potentially more viable for patients who couldn't previously tolerate the procedure — those with severely reduced cardiac function or multi-vessel disease.
Why it matters: Higher pulse frequencies fundamentally change IVL's risk-benefit equation. Reducing repeated balloon inflations makes IVL potentially more viable for patients who couldn't previously tolerate the procedure — those with severely reduced cardiac function or multi-vessel disease.
How Does Energy Control Vary Across IVL Systems?
Pulse frequency tells only half the story. Equally critical is how physicians control where energy is delivered within the treatment zone. This can have profound implications for procedural efficiency and patient outcomes.
Traditional IVL systems essentially function as "fixed cannons" — they fire energy at predetermined points within the balloon, with no ability to adjust targeting during treatment. Next-generation systems are changing this paradigm by giving physicians real-time control over energy delivery without requiring the physician to reposition the catheter.
First-generation IVL systems: Use fixed emitters embedded along the balloon that discharge energy in a set sequence. In some peripheral systems, peak energy is delivered from the center electrode, requiring the operator to precisely center it on the densest plaque. While the spacing and firing sequence can vary between devices, this design may leave small untreated gaps along the vessel — sometimes requiring the operator to deflate and reposition the balloon to cover the entire target area.
FastWave Artero™: Features independently powered emitters longitudinally spaced along the balloon, providing consistent and uniform energy delivery across the treatment zone.²
FastWave Sola™: Provides precise energy control via a single translating emitter. Operators can actuate the emitter along the length of the inflated balloon — delivering energy exactly where needed without having to reposition the catheter.
How Does Energy Control Vary Across IVL Systems?
Pulse frequency tells only half the story. Equally critical is how physicians control where energy is delivered within the treatment zone. This can have profound implications for procedural efficiency and patient outcomes.
Traditional IVL systems essentially function as "fixed cannons" — they fire energy at predetermined points within the balloon, with no ability to adjust targeting during treatment. Next-generation systems are changing this paradigm by giving physicians real-time control over energy delivery without requiring the physician to reposition the catheter.
First-generation IVL systems: Use fixed emitters embedded along the balloon that discharge energy in a set sequence. In some peripheral systems, peak energy is delivered from the center electrode, requiring the operator to precisely center it on the densest plaque. While the spacing and firing sequence can vary between devices, this design may leave small untreated gaps along the vessel — sometimes requiring the operator to deflate and reposition the balloon to cover the entire target area.
FastWave Artero™: Features independently powered emitters longitudinally spaced along the balloon, providing consistent and uniform energy delivery across the treatment zone.²
FastWave Sola™: Provides precise energy control via a single translating emitter. Operators can actuate the emitter along the length of the inflated balloon — delivering energy exactly where needed without having to reposition the catheter.
How Does Energy Control Vary Across IVL Systems?
Pulse frequency tells only half the story. Equally critical is how physicians control where energy is delivered within the treatment zone. This can have profound implications for procedural efficiency and patient outcomes.
Traditional IVL systems essentially function as "fixed cannons" — they fire energy at predetermined points within the balloon, with no ability to adjust targeting during treatment. Next-generation systems are changing this paradigm by giving physicians real-time control over energy delivery without requiring the physician to reposition the catheter.
First-generation IVL systems: Use fixed emitters embedded along the balloon that discharge energy in a set sequence. In some peripheral systems, peak energy is delivered from the center electrode, requiring the operator to precisely center it on the densest plaque. While the spacing and firing sequence can vary between devices, this design may leave small untreated gaps along the vessel — sometimes requiring the operator to deflate and reposition the balloon to cover the entire target area.
FastWave Artero™: Features independently powered emitters longitudinally spaced along the balloon, providing consistent and uniform energy delivery across the treatment zone.²
FastWave Sola™: Provides precise energy control via a single translating emitter. Operators can actuate the emitter along the length of the inflated balloon — delivering energy exactly where needed without having to reposition the catheter.
How Does Energy Control Vary Across IVL Systems?
Pulse frequency tells only half the story. Equally critical is how physicians control where energy is delivered within the treatment zone. This can have profound implications for procedural efficiency and patient outcomes.
Traditional IVL systems essentially function as "fixed cannons" — they fire energy at predetermined points within the balloon, with no ability to adjust targeting during treatment. Next-generation systems are changing this paradigm by giving physicians real-time control over energy delivery without requiring the physician to reposition the catheter.
First-generation IVL systems: Use fixed emitters embedded along the balloon that discharge energy in a set sequence. In some peripheral systems, peak energy is delivered from the center electrode, requiring the operator to precisely center it on the densest plaque. While the spacing and firing sequence can vary between devices, this design may leave small untreated gaps along the vessel — sometimes requiring the operator to deflate and reposition the balloon to cover the entire target area.
FastWave Artero™: Features independently powered emitters longitudinally spaced along the balloon, providing consistent and uniform energy delivery across the treatment zone.²
FastWave Sola™: Provides precise energy control via a single translating emitter. Operators can actuate the emitter along the length of the inflated balloon — delivering energy exactly where needed without having to reposition the catheter.
FastWave’s Sola™ L-IVL system in action. Sola™ provides operators with complete control to translate a single emitter along the balloon to deliver energy exactly where it’s needed.
Why it matters: Energy control determines procedural efficacy and treatment precision. Traditional IVL systems force physicians to deflate, reposition, and re-inflate balloons multiple times — increasing case time, adding workflow friction, and creating additional challenges related to prolonged ischemia. Next-generation IVL platforms, like FastWave, aim to deliver comprehensive therapy with minimal balloon repositioning — reducing patient risk while enabling predictable treatment of complex calcified lesions.
Why it matters: Energy control determines procedural efficacy and treatment precision. Traditional IVL systems force physicians to deflate, reposition, and re-inflate balloons multiple times — increasing case time, adding workflow friction, and creating additional challenges related to prolonged ischemia. Next-generation IVL platforms, like FastWave, aim to deliver comprehensive therapy with minimal balloon repositioning — reducing patient risk while enabling predictable treatment of complex calcified lesions.
Why it matters: Energy control determines procedural efficacy and treatment precision. Traditional IVL systems force physicians to deflate, reposition, and re-inflate balloons multiple times — increasing case time, adding workflow friction, and creating additional challenges related to prolonged ischemia. Next-generation IVL platforms, like FastWave, aim to deliver comprehensive therapy with minimal balloon repositioning — reducing patient risk while enabling predictable treatment of complex calcified lesions.
Why it matters: Energy control determines procedural efficacy and treatment precision. Traditional IVL systems force physicians to deflate, reposition, and re-inflate balloons multiple times — increasing case time, adding workflow friction, and creating additional challenges related to prolonged ischemia. Next-generation IVL platforms, like FastWave, aim to deliver comprehensive therapy with minimal balloon repositioning — reducing patient risk while enabling predictable treatment of complex calcified lesions.
How Do Pulse Frequency and Control Affect Physician Workflows?
When faster pulse rates combine with advanced energy control, they fundamentally change how physicians can approach IVL procedures.
With legacy technology — as described above — IVL therapy is delivered in a stop-start fashion: short bursts of energy followed by deflation, waiting, and repositioning. Excluding inflation and balloon repositioning time, it typically takes an interventional cardiologist over four minutes to deliver 120 pulses for coronary applications.³ These cycles prolong the procedure, which can be problematic for patients who already suffer from compromised cardiac output.
Next-generation IVL systems transform this into a smoother process. Rapid, continuous energy delivery means fewer interruptions, while advanced features minimize the need for catheter repositioning. What previously required over four minutes across multiple positions in a coronary aratery can now be accomplished in approximately one-fourth of the time.⁴
These workflow improvements create multiple potential benefits. With predictable, rapid energy delivery, physicians have more control when treating complex calcified lesions. The reduced procedural complexity and increased efficiency could also make IVL more accessible to physicians newer to the technology, potentially expanding its adoption across more centers and patient populations.
How Do Pulse Frequency and Control Affect Physician Workflows?
When faster pulse rates combine with advanced energy control, they fundamentally change how physicians can approach IVL procedures.
With legacy technology — as described above — IVL therapy is delivered in a stop-start fashion: short bursts of energy followed by deflation, waiting, and repositioning. Excluding inflation and balloon repositioning time, it typically takes an interventional cardiologist over four minutes to deliver 120 pulses for coronary applications.³ These cycles prolong the procedure, which can be problematic for patients who already suffer from compromised cardiac output.
Next-generation IVL systems transform this into a smoother process. Rapid, continuous energy delivery means fewer interruptions, while advanced features minimize the need for catheter repositioning. What previously required over four minutes across multiple positions in a coronary aratery can now be accomplished in approximately one-fourth of the time.⁴
These workflow improvements create multiple potential benefits. With predictable, rapid energy delivery, physicians have more control when treating complex calcified lesions. The reduced procedural complexity and increased efficiency could also make IVL more accessible to physicians newer to the technology, potentially expanding its adoption across more centers and patient populations.
How Do Pulse Frequency and Control Affect Physician Workflows?
When faster pulse rates combine with advanced energy control, they fundamentally change how physicians can approach IVL procedures.
With legacy technology — as described above — IVL therapy is delivered in a stop-start fashion: short bursts of energy followed by deflation, waiting, and repositioning. Excluding inflation and balloon repositioning time, it typically takes an interventional cardiologist over four minutes to deliver 120 pulses for coronary applications.³ These cycles prolong the procedure, which can be problematic for patients who already suffer from compromised cardiac output.
Next-generation IVL systems transform this into a smoother process. Rapid, continuous energy delivery means fewer interruptions, while advanced features minimize the need for catheter repositioning. What previously required over four minutes across multiple positions in a coronary aratery can now be accomplished in approximately one-fourth of the time.⁴
These workflow improvements create multiple potential benefits. With predictable, rapid energy delivery, physicians have more control when treating complex calcified lesions. The reduced procedural complexity and increased efficiency could also make IVL more accessible to physicians newer to the technology, potentially expanding its adoption across more centers and patient populations.
How Do Pulse Frequency and Control Affect Physician Workflows?
When faster pulse rates combine with advanced energy control, they fundamentally change how physicians can approach IVL procedures.
With legacy technology — as described above — IVL therapy is delivered in a stop-start fashion: short bursts of energy followed by deflation, waiting, and repositioning. Excluding inflation and balloon repositioning time, it typically takes an interventional cardiologist over four minutes to deliver 120 pulses for coronary applications.³ These cycles prolong the procedure, which can be problematic for patients who already suffer from compromised cardiac output.
Next-generation IVL systems transform this into a smoother process. Rapid, continuous energy delivery means fewer interruptions, while advanced features minimize the need for catheter repositioning. What previously required over four minutes across multiple positions in a coronary aratery can now be accomplished in approximately one-fourth of the time.⁴
These workflow improvements create multiple potential benefits. With predictable, rapid energy delivery, physicians have more control when treating complex calcified lesions. The reduced procedural complexity and increased efficiency could also make IVL more accessible to physicians newer to the technology, potentially expanding its adoption across more centers and patient populations.
Why it matters: Streamlined workflows don't just save time — they reduce cognitive load, minimize coordination complexity, and create more predictable procedural outcomes. When physicians can focus on case strategy rather than managing technical limitations, there’s a higher likelihood that both efficiency and clinical results may improve.
Why it matters: Streamlined workflows don't just save time — they reduce cognitive load, minimize coordination complexity, and create more predictable procedural outcomes. When physicians can focus on case strategy rather than managing technical limitations, there’s a higher likelihood that both efficiency and clinical results may improve.
Why it matters: Streamlined workflows don't just save time — they reduce cognitive load, minimize coordination complexity, and create more predictable procedural outcomes. When physicians can focus on case strategy rather than managing technical limitations, there’s a higher likelihood that both efficiency and clinical results may improve.
Why it matters: Streamlined workflows don't just save time — they reduce cognitive load, minimize coordination complexity, and create more predictable procedural outcomes. When physicians can focus on case strategy rather than managing technical limitations, there’s a higher likelihood that both efficiency and clinical results may improve.
The Bottom Line on IVL Energy Control
While all IVL systems aim to fracture calcium safely, the speed and precision of energy delivery can fundamentally alter physician workflow and procedural success. Legacy technology with slower pulse rates and fixed emitters can create procedural friction — which may force physicians into cycles of balloon repositioning, extending procedure time, and limiting treatment predictability, especially for complex calcified lesions.
FastWave’s Artero™ and Sola™ compress traditional multi-step workflows into streamlined procedures, reducing cognitive load while potentially expanding the spectrum of treatable lesions.
As IVL continues to evolve, pulse frequency and energy control will increasingly determine which IVL technology clinicians choose for their challenging cases.
The Bottom Line on IVL Energy Control
While all IVL systems aim to fracture calcium safely, the speed and precision of energy delivery can fundamentally alter physician workflow and procedural success. Legacy technology with slower pulse rates and fixed emitters can create procedural friction — which may force physicians into cycles of balloon repositioning, extending procedure time, and limiting treatment predictability, especially for complex calcified lesions.
FastWave’s Artero™ and Sola™ compress traditional multi-step workflows into streamlined procedures, reducing cognitive load while potentially expanding the spectrum of treatable lesions.
As IVL continues to evolve, pulse frequency and energy control will increasingly determine which IVL technology clinicians choose for their challenging cases.
The Bottom Line on IVL Energy Control
While all IVL systems aim to fracture calcium safely, the speed and precision of energy delivery can fundamentally alter physician workflow and procedural success. Legacy technology with slower pulse rates and fixed emitters can create procedural friction — which may force physicians into cycles of balloon repositioning, extending procedure time, and limiting treatment predictability, especially for complex calcified lesions.
FastWave’s Artero™ and Sola™ compress traditional multi-step workflows into streamlined procedures, reducing cognitive load while potentially expanding the spectrum of treatable lesions.
As IVL continues to evolve, pulse frequency and energy control will increasingly determine which IVL technology clinicians choose for their challenging cases.
The Bottom Line on IVL Energy Control
While all IVL systems aim to fracture calcium safely, the speed and precision of energy delivery can fundamentally alter physician workflow and procedural success. Legacy technology with slower pulse rates and fixed emitters can create procedural friction — which may force physicians into cycles of balloon repositioning, extending procedure time, and limiting treatment predictability, especially for complex calcified lesions.
FastWave’s Artero™ and Sola™ compress traditional multi-step workflows into streamlined procedures, reducing cognitive load while potentially expanding the spectrum of treatable lesions.
As IVL continues to evolve, pulse frequency and energy control will increasingly determine which IVL technology clinicians choose for their challenging cases.
Sources and References
Sources and References
Sources and References
Sources and References
